The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy
- PMID: 33295153
- PMCID: PMC8451373
- DOI: 10.1002/cnr2.1317
The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy
Abstract
Background: Quality of life can be influenced by oral mucositis (OM), and it is necessary to implement OM management strategies before the initiation of radiotherapy (RT) in patients with head and neck cancer (HNC).
Aims: To examine the association between the cumulative radiation dose and the incidence of severe OM in HNC patients receiving RT.
Methods and results: A retrospective observational cohort study was conducted in a Showa University Fujigaoka Hospital, in Japan. We retrospectively analyzed 94 patients with HNC who developed OM during RT. We defined OM as a more than grade 2 OM. The cumulative incidence of OM curves of the two categories was estimated using the Kaplan-Meier method and compared using the log-rank test. We estimated the hazard ratio (HR) for OM after the adjustment of factors for covariates using Cox's regression analysis. Patients with smoking history had a significantly later development of OM than those with no smoking history (20 Gy-incidence OM 68.7% vs 39.7%, P = .003). In contrast, patients undergoing concurrent chemotherapy had an earlier development of OM than those undergoing RT alone (20 Gy-incidence OM 24.2% vs 55.7%, P < .001). Multivariate analysis revealed that no smoking history and concurrent chemotherapy were independent predictive factors, with a HR of 0.526 (P = .025) and 2.690 (P < .001), respectively.
Conclusion: We demonstrated that no smoking history and concurrent chemotherapy may be predictive of OM in HNC patients.
Keywords: concurrent chemotherapy; cumulative radiation dose; head and neck cancer; oral mucositis; predictive factors; radiotherapy.
© 2020 The Authors. Cancer Reports published by Wiley Periodicals LLC.
Conflict of interest statement
The authors have no conflicts of interest to report.
Figures
Similar articles
-
The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors.Ear Nose Throat J. 2025 May;104(5):NP257-NP269. doi: 10.1177/01455613241228211. Epub 2024 Feb 9. Ear Nose Throat J. 2025. PMID: 38334289
-
Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.Support Care Cancer. 2017 May;25(5):1439-1443. doi: 10.1007/s00520-016-3548-9. Epub 2016 Dec 16. Support Care Cancer. 2017. PMID: 27987094 Clinical Trial.
-
Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.Trials. 2019 Feb 1;20(1):97. doi: 10.1186/s13063-019-3196-8. Trials. 2019. PMID: 30709370 Free PMC article.
-
Zinc Supplementation for Mitigating Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Chemoradiotherapy - A Systematic Review.Clin Nutr ESPEN. 2025 Jun;67:8-24. doi: 10.1016/j.clnesp.2025.02.011. Epub 2025 Feb 25. Clin Nutr ESPEN. 2025. PMID: 40015604
-
Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data.Oral Oncol. 2019 Aug;95:29-34. doi: 10.1016/j.oraloncology.2019.05.013. Epub 2019 Jun 6. Oral Oncol. 2019. PMID: 31345391 Review.
Cited by
-
Oral Candida spp. Colonisation Is a Risk Factor for Severe Oral Mucositis in Patients Undergoing Radiotherapy for Head & Neck Cancer: Results from a Multidisciplinary Mono-Institutional Prospective Observational Study.Cancers (Basel). 2022 Sep 29;14(19):4746. doi: 10.3390/cancers14194746. Cancers (Basel). 2022. PMID: 36230669 Free PMC article.
-
Predictive Factors for Chemoradiation-Induced Oral Mucositis and Dysphagia in Head and Neck Cancer: A Scoping Review.Cancers (Basel). 2023 Dec 4;15(23):5705. doi: 10.3390/cancers15235705. Cancers (Basel). 2023. PMID: 38067408 Free PMC article.
-
[Performance of multi-modality and multi-classifier fusion models for predicting radiation-induced oral mucositis in patients with nasopharyngeal carcinoma].Nan Fang Yi Ke Da Xue Xue Bao. 2024 Dec 20;44(12):2434-2442. doi: 10.12122/j.issn.1673-4254.2024.12.20. Nan Fang Yi Ke Da Xue Xue Bao. 2024. PMID: 39725633 Free PMC article. Chinese.
-
L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial.J Cancer Res Clin Oncol. 2025 Jul 3;151(7):198. doi: 10.1007/s00432-025-06213-x. J Cancer Res Clin Oncol. 2025. PMID: 40603739 Free PMC article. Clinical Trial.
-
Risk factor and prediction model development for severe radiation-induced oral mucositis in head and neck tumors.Future Oncol. 2024;20(31):2385-2395. doi: 10.1080/14796694.2024.2384353. Epub 2024 Aug 6. Future Oncol. 2024. PMID: 39105623 Free PMC article.
References
-
- Hata H, Ota Y, Ueno T, et al. Oral mucositis frequency in head and neck chemoradiotherapy. Toukeibugan. 2007;33:48‐53.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical